Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-05 · accession 0001415889-24-007081 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-03-06 | 2024-03-05 | OLMA | RAPPAPORT ANDREW | Dir | J - Other | $0.00 | -95.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | J | A | 385,965 | $0.00 | 385,965 | I See Footnote | — | — | (F3) The shares are held by the Rappaport Family Trust, of which the reporting person is co-trustee. |
| 2 | Common | Common Stock | 2024-03-05 | J | D | 481,014 | $0.00 | 0 | I See Footnote | — | — | (F2) The shares were held by SPWI. |